Ascentage Pharma Group International ratios data for the quarter ended Jun 2026. These financial ratios cover 5 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2023 | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|
| Efficiency | |||||
| Inventory AverageInventory Avg. | 1.58M | 1.06M | 2.62M | 6.76M | |
| Assets AverageAssets Avg. | 1,756.01M | ||||
| Invested CapitalInvested Cap. | 12.35M | ||||
| Leverage & Solvency | |||||
| Debt Ratio | 0.01 | ||||
| Valuation | |||||
| Price to BookP/B | 13.02 | ||||
| Enterprise Value | 3,198.98M | 2,102.10M | 1,360.50M | ||
| Market Capitalization | 3,428.68M | 2,448.99M | 1,638.88M | ||
| Price to FCFP/FCF | -42.15 | ||||
| EV to FCF | -36.18 | ||||
| EV to CFO | -34.50 |